Purchase

Recombinant Human TFF1 protein (rFc Tag)

Species

Human

Purity

>90 %, SDS-PAGE
>90 %, SEC-HPLC

Tag

rFc Tag

Activity

not tested

Cat no : Eg3073


Product Information

Purity >90 %, SDS-PAGE
>90 %, SEC-HPLC
Endotoxin <0.1 EU/μg protein, LAL method
Activity
Not tested
Expression HEK293-derived Human TFF1 protein Glu25-Phe84 (Accession# P04155) with a rabbit IgG Fc tag at the C-terminus.
GeneID 7031
Accession P04155
PredictedSize 32.7 kDa
SDS-PAGE 35-40 kDa, reducing (R) conditions
Formulation Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
Reconstitution Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
Storage Conditions
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

Background

TFF1 (Trefoil factor 1, formerly known as pS2) is a small-secreted protein that belongs to the family of trefoil peptides, and characterized by the presence of one to six cysteine-rich P domains. TFF1 expression is frequently lost in gastric carcinoma, probably through mechanism of DNA methylation, and it is therefore considered as a tumor suppressor gene. The function of TFF1 was first controversially considered as an oncogene in breast cancer.

References:

1. Li J, Xia N, et al. (2022) Adv Sci (Weinh). 9(9):e2104338. 2. Okamoto M, Kuratani A, et al. (2024) Front Immunol. 15:1440918. 3. Busch MA, Haase A, et al. (2022) Cancers (Basel). 14(3):677. 4. Shah A, Jahan R, et al. (2024) Cancer Lett. 598:217097.